The Importance of Myocardial Protection and Other Markers in Cardiac Surgery
Letter to the Editor
DOI:
https://doi.org/10.5281/zenodo.11076507Keywords:
Anatolia, Cor, International, Heart, Journal, Cardiac, Surgery, Myocardial Protection, Cardiopulnary, Bypass, Heart DiseasesAbstract
Dear Editor,
The aim of this study is to provide information about perfusion markers used in cardiac surgery and to emphasise the importance of these markers in clinical practice.
Perfusion markers are important tools used to evaluate the circulatory status of the heart and myocardial oxygenation during cardiac surgery. These markers may include various measurements such as perfusion pressure, blood gases, lactate levels, some biochemical parameters. Clinical monitoring of these markers is critical in assessing the patient's cardiovascular status and guiding the treatment plan if necessary.
Studies show that perfusion markers play an important role in determining the risk of morbidity and mortality after cardiac surgery. In particular, monitoring of these markers in case of inadequate perfusion or deterioration of circulatory status allows early diagnosis and intervention of possible complications. This may significantly affect the clinical outcome of the patient.
In this context, further research is needed for a more widespread use of perfusion markers in clinical practice and a better understanding of the meaning of these markers. Furthermore, the use of these markers should be standardised and monitored by highly trained healthcare personnel (1-3).
I would like to ask you to support the publication of articles that will provide more information on perfusion markers and bring this important topic to a wider audience.
Best regards.
References
Ranucci M, De Toffol B, Isgro G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Critical Care. 2006;10(6):R167. doi:10.1186/cc5113
Breuer T, Martin K, Wilhelm M, Wiesner G, Chappell D, Rehm M. Impact of perioperative dextran on microcirculation and clinical outcome in patients undergoing coronary artery bypass grafting. The Annals of Thoracic Surgery. 2007;83(4):1514-1521. doi:10.1016/j.athoracsur.2006.10.079
Kogan A, Preisman S, Levin S, Raanani E, Sternik L. The impact of hyperlactatemia on postoperative outcome after adult cardiac surgery. Journal of Anesthesia. 2009;23(3):322-328. doi:10.1007/s00540-009-0760-1
Matte GS, del Nido PJ. History and Use of Del Nido Cardioplegia Solution at Boston Children's Hospital. J Extra Corpor Technol. 2012 Dec;44(4):98-103. PMID: 23447938; PMCID: PMC4681270.
Timek TA, Willekes CL, Beute T, et al. Del Nido cardioplegia for minimally invasive aortic valve surgery. J Card Surg. 2019;34(11):1185-1189. doi:10.1111/jocs.14179.
Badhwar V, Hsu JY, Toyoda N, et al. The del Nido cardioplegia infusion: a single-center experience with 1,728 patients. J Thorac Cardiovasc Surg. 2015;149(3):982-989. doi:10.1016/j.jtcvs.2014.11.040.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anatolia Cor
This work is licensed under a Creative Commons Attribution 4.0 International License.